Provided by Tiger Fintech (Singapore) Pte. Ltd.

3SBIO

7.500
+0.0300.40%
Volume:29.04M
Turnover:217.72M
Market Cap:17.97B
PE:11.02
High:7.760
Open:7.470
Low:7.300
Close:7.470
Loading ...

3SBio Inc.'s (HKG:1530) Stock Is Going Strong: Have Financials A Role To Play?

Simply Wall St.
·
13 Feb

BRIEF-3SBio Announces Cooperation With Duality Biologics In Respect Of Her2 Adc Drug

Reuters
·
13 Jan

3SBio Unit Gets Commercialization Rights for Duality Biologics' Cancer Drug in China, Hong Kong, Macau

MT Newswires Live
·
13 Jan

3SBio - Cooperation Between 3SBio Inc. and Duality Biologics in Respect of Her2 ADC Drug

THOMSON REUTERS
·
13 Jan

3SBio Cancels All Treasury Shares

MT Newswires Live
·
18 Dec 2024

3SBio's Unit Gets Exclusive Commercialization Rights for Clifutinib Besylate in Mainland China

MT Newswires Live
·
26 Nov 2024

BRIEF-3SBio Announces Cooperation Between Shenyang Sunshine And Sunshine Lake Pharma

Reuters
·
25 Nov 2024

3SBio - Cooperation Between Shenyang Sunshine and Sunshine Lake Pharma in Respect of Clifutinib Besylate

THOMSON REUTERS
·
25 Nov 2024

The five-year underlying earnings growth at 3SBio (HKG:1530) is promising, but the shareholders are still in the red over that time

Simply Wall St.
·
25 Nov 2024

BRIEF-3SBio Says CFO Increased Shareholding In Co

Reuters
·
14 Nov 2024

3SBio's CFO Boosts Stakeholding

MT Newswires Live
·
14 Nov 2024

3SBio - Since 1 Jan to 14 Nov, CFO Increased Shareholding in Co by Aggregate of 3.0 Mln Ordinary Shares at HKD5.99 per Share

THOMSON REUTERS
·
14 Nov 2024

Declining Stock and Decent Financials: Is The Market Wrong About 3SBio Inc. (HKG:1530)?

Simply Wall St.
·
30 Oct 2024

3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution

MT Newswires Live
·
24 Oct 2024

BRIEF-3SBio Says Unit Entered Exclusive Commercialization Cooperation Agreement

Reuters
·
24 Oct 2024

3SBio - Shenyang Sunshine Will Obtain Exclusive Commercialization Rights of Rmx Biopharma's Product of Paclitaxel Oral Solution

THOMSON REUTERS
·
24 Oct 2024